GSE202182
A specific molecular signature in SARS-CoV-2 infected kidney biopsies
To characterize the pathophysiology of kidney injury in a large kidney biopsy series of living SARS-CoV-2–infected patients RNA-seq was performed to compare transcriptional changes in damaged kidneys of COVID-19 patients to those of healthy, non-COVID-19 injured kidneys and Hantavirus injured kidney Overall design: Comparative gene expression profiling analysis of RNA-seq data for kidney samples of COVID-19 patients to those of healthy, non-COVID-19 injured kidneys and Hantavirus injured kidneys